AMY JORDAN: Open Payments
NPI 1699516500 · BRISTOL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,067 in 54 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $192 · 2025 $1,067
Food & beverage: $1,067
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $245 |
| Novartis Pharmaceuticals Corporation | 13 | $243 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $122 |
| Merck Sharp & Dohme LLC | 6 | $113 |
| E.R. Squibb & Sons, L.L.C. | 5 | $84 |
| Novo Nordisk Inc | 3 | $78 |
| BridgeBio Pharma, Inc. | 3 | $77 |
| Amgen Inc. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $16 |
Products named: LEQVIO, Kerendia, FARXIGA, VERQUVO, Attruby, CAMZYOS, WAINUA, Wegovy.
Industry payments across TN — which companies pay providers there.
